- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
EKF
LSE
Week ended 07 Aug 2026
Weekly Investor Report
EKF Diagnostics Holdings plc · Healthcare · Medical Devices
Latest close
0.26 GBP
1.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 1.4% above the Trend Line and sits at 41.2% of its 52-week range. The latest completed week returned 1.2%, after a 2.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.
Setup score
40
out of 100
Latest Close
0.26 GBP
7 Aug 2026
1W Return
1.2%
latest completed week
4W Return
2.4%
short-term follow-through
12W Return
-2.8%
quarterly tape
Trend Breadth
42.3%
22 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 38.26% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.2%
Latest completed week; four-week move 2.4%.
Indicator stack
27/46
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.26%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
15 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 1.4% above the Trend Line and sits at 41.2% of its 52-week range. The latest completed week returned 1.2%, after a 2.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4312-week average 0.30
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.43Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.4% over four weeks, -2.8% over 12 weeks, and -13.6% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year22
Trend breadth42.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.10Latest activity-pressure read.
Pressure change-78.9%Four-week change in activity pressure.
Leadership-8.92Latest relative-leadership reading.
RS change7.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 82%
Model confidence 65%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength67/100Blend of value, momentum, and quality. Underlying universe rank 34; rank 1 is best.
Value61/100Relative valuation strength. Underlying universe rank 40; rank 1 is best.
Quality62/100Profitability and accounting quality. Underlying universe rank 39; rank 1 is best.
Momentum63/100Medium-term price momentum. Underlying universe rank 38; rank 1 is best.
Growth63/100Revenue and earnings growth. Underlying universe rank 38; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework40/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 51.4% Gross profit retained from each unit of revenue.
- Operating margin
- 13.5% Operating profit retained from revenue.
- Free-cash-flow margin
- 14.2% Free cash flow generated from revenue.
- Return on invested capital
- 9.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 2.7% Latest one-year revenue growth.
- EPS growth
- -64.4% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -32.7% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- - Net share repurchases relative to market value.
- Shareholder yield
- - Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -1.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 15 relevant articles.
1 positive · 13 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-18.8%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2612 weeks finished lower.
Best week+8.4%Week of 1 May.
Worst week-6.2%Week of 20 Mar.
Latest week+1.2%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains9
Flat weeks2
Modest losses9
Sharp losses3
Recent vol3.4%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split23/27Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Healthcare
4-week rank32 / 79
Group average0.0%
Trend breadth27.8%
Trend27.8%active weekly trend signals
MD44.3%positive activity pressure
RS22.8%positive relative leadership
Four-week leaders
IndustryGB Medical Devices
4-week rank5 / 9
Group average6.9%
Trend breadth55.6%
Trend55.6%active weekly trend signals
MD77.8%positive activity pressure
RS22.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape37/100
Trend, activity pressure, participation, and risk combine to a 37/100 tape read.
Indicator analysis58/100Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.43; No reversal markers Next-Week ExpectancyNegative 38.26%Next-week expectancy is negative with a 38.26% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors62/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 50 SVQF40/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 211.5 of 351 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 15 relevant articles.
EKF Diagnostics buys back 150,000 shares at 25.5p each By Investing.com Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.26 GBP | 1.2% | 0.26 GBP | 0.27 GBP | 0.10 | -8.92 | 1.2M | On |
| 31 Jul 2026 | 0.26 GBP | 0.0% | 0.26 GBP | 0.27 GBP | 0.21 | -10.30 | 1.7M | Off |
| 24 Jul 2026 | 0.26 GBP | 2.0% | 0.26 GBP | 0.27 GBP | 0.32 | -9.89 | 463.6K | Off |
| 17 Jul 2026 | 0.25 GBP | -0.8% | 0.26 GBP | 0.27 GBP | 0.52 | -10.84 | 2.5M | On |
| 10 Jul 2026 | 0.25 GBP | -3.4% | 0.26 GBP | 0.27 GBP | 0.48 | -9.60 | 362.0K | On |
| 3 Jul 2026 | 0.26 GBP | -2.6% | 0.26 GBP | 0.27 GBP | 0.41 | -8.31 | 42.0K | On |
| 26 Jun 2026 | 0.27 GBP | 4.2% | 0.26 GBP | 0.27 GBP | 0.41 | -4.73 | 331.1K | On |
| 19 Jun 2026 | 0.26 GBP | 3.6% | 0.25 GBP | 0.27 GBP | 0.35 | -7.66 | 177.2K | On |
| 12 Jun 2026 | 0.25 GBP | -5.3% | 0.25 GBP | 0.27 GBP | 0.54 | -12.11 | 143.5K | On |
| 5 Jun 2026 | 0.26 GBP | -1.3% | 0.25 GBP | 0.27 GBP | 0.72 | -6.65 | 1.1M | On |
| 29 May 2026 | 0.27 GBP | -2.7% | 0.25 GBP | 0.27 GBP | 0.55 | -6.12 | 214.9K | On |
| 22 May 2026 | 0.28 GBP | 2.8% | 0.25 GBP | 0.27 GBP | 0.48 | -4.21 | 2.0M | On |
| 15 May 2026 | 0.27 GBP | 7.0% | 0.25 GBP | 0.27 GBP | -0.03 | -4.53 | 876.2K | Off |
| 8 May 2026 | 0.25 GBP | -5.8% | 0.25 GBP | 0.27 GBP | -0.43 | -11.32 | 675.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.